[go: up one dir, main page]

DE69017794D1 - Aminoketonderivate und ihre Verwendung. - Google Patents

Aminoketonderivate und ihre Verwendung.

Info

Publication number
DE69017794D1
DE69017794D1 DE69017794T DE69017794T DE69017794D1 DE 69017794 D1 DE69017794 D1 DE 69017794D1 DE 69017794 T DE69017794 T DE 69017794T DE 69017794 T DE69017794 T DE 69017794T DE 69017794 D1 DE69017794 D1 DE 69017794D1
Authority
DE
Germany
Prior art keywords
aminoketone
aminoketone derivatives
pollakiurea
chem
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69017794T
Other languages
English (en)
Other versions
DE69017794T2 (de
Inventor
Akira Matsubara
Kazuya Sakai
Hideki Tanada
Akira Mizuchi
Kazutoshi Horikomi
Hideshi Shimizu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Publication of DE69017794D1 publication Critical patent/DE69017794D1/de
Application granted granted Critical
Publication of DE69017794T2 publication Critical patent/DE69017794T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
DE69017794T 1989-08-04 1990-08-01 Aminoketonderivate und ihre Verwendung. Expired - Fee Related DE69017794T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20141089 1989-08-04

Publications (2)

Publication Number Publication Date
DE69017794D1 true DE69017794D1 (de) 1995-04-20
DE69017794T2 DE69017794T2 (de) 1995-08-03

Family

ID=16440623

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69017794T Expired - Fee Related DE69017794T2 (de) 1989-08-04 1990-08-01 Aminoketonderivate und ihre Verwendung.

Country Status (10)

Country Link
EP (1) EP0414391B1 (de)
JP (1) JPH0625178B2 (de)
KR (1) KR920009062B1 (de)
CN (1) CN1040105C (de)
AT (1) ATE119890T1 (de)
CA (1) CA2022462A1 (de)
DE (1) DE69017794T2 (de)
DK (1) DK0414391T3 (de)
FI (1) FI96856C (de)
NO (1) NO180269C (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338857A (en) * 1989-08-04 1994-08-16 Mitsui Toatsu Chemicals Incorporated Aminoketone derivatives of 1,2-oxazole and use thereof
US5055585A (en) * 1990-02-08 1991-10-08 Mitsui Toatsu Chemicals, Incorporated Preparation process of aminoketones
US5194606A (en) * 1990-02-08 1993-03-16 Mitsui Toatsu Chemicals, Incorporated Preparation process of aminoketones
JP3164631B2 (ja) * 1991-02-26 2001-05-08 三井化学株式会社 光学活性アミノケトン誘導体及びその製造法
WO1996010567A1 (en) * 1994-09-30 1996-04-11 Maruho Co., Ltd. Aminoketone derivative, physiologically acceptable salt thereof, and use of the same
US5693804A (en) * 1994-11-17 1997-12-02 Molecular Geriatrics Corporation Substituted 1-aryl-3-piperazin-1'-yl propanones
US6214994B1 (en) 1997-04-21 2001-04-10 Molecular Geriatrics Corporation Certain substituted 1-aryl-3-piperazin-1′-yl propanones
DE10240026A1 (de) * 2002-08-27 2004-03-11 Merck Patent Gmbh Verfahren zur Herstellung von Monoalkylaminoketonen
JP3789465B1 (ja) 2005-04-28 2006-06-21 学校法人立教学院 イソオキサゾール誘導体又はジヒドロイソオキサゾール誘導体の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE307581B (de) * 1963-07-31 1969-01-13 Shionogi & Co
JPS5862169A (ja) * 1981-10-09 1983-04-13 Nippon Kayaku Co Ltd 新規な５−アミノイソオキサゾ−ル誘導体
JPS58201770A (ja) * 1982-05-18 1983-11-24 Dainippon Pharmaceut Co Ltd α−置換−１，２−ベンズイソキサゾ−ル−３−酢酸エステル類並びにその酸付加塩類及び第４級アンモニウム塩類
AU4261285A (en) * 1984-06-01 1985-12-05 Tokyo Tanabe Company Limited 1-propanone derivatives
JPH0637389B2 (ja) * 1986-12-26 1994-05-18 北陸製薬株式会社 頻尿治療剤
US4980365A (en) * 1987-07-13 1990-12-25 Hoechst-Roussel Pharmaceuticals Inc. N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents
IE62276B1 (en) * 1988-03-30 1995-01-25 Sankyo Co "New isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants"

Also Published As

Publication number Publication date
EP0414391A2 (de) 1991-02-27
NO903430L (no) 1991-02-05
AU5998790A (en) 1991-02-07
NO180269B (no) 1996-12-09
EP0414391B1 (de) 1995-03-15
CA2022462A1 (en) 1991-02-05
JPH0625178B2 (ja) 1994-04-06
JPH03157375A (ja) 1991-07-05
DK0414391T3 (da) 1995-04-03
KR920009062B1 (ko) 1992-10-13
CN1040105C (zh) 1998-10-07
NO180269C (no) 1997-03-19
FI903833A0 (fi) 1990-08-01
KR910004609A (ko) 1991-03-29
AU615621B2 (en) 1991-10-03
EP0414391A3 (en) 1991-07-17
DE69017794T2 (de) 1995-08-03
CN1049660A (zh) 1991-03-06
FI96856C (fi) 1996-09-10
NO903430D0 (no) 1990-08-03
ATE119890T1 (de) 1995-04-15
FI96856B (fi) 1996-05-31

Similar Documents

Publication Publication Date Title
PT87552A (pt) Process for the preparation of novel tetrazole intermediates toantihypertensive compounds
DE69108138D1 (de) Imidazopyridinderivate und ihre Verwendung.
NO892058D0 (no) Fremgangsnaate for fremstilling av terapeutisk aktive benzamider.
ATE74132T1 (de) Imid-derivate, ihre herstellung und ihre verwendung.
ES2174298T3 (es) Derivados de aminotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BG100069A (bg) Амидинови производни,съдържащи хетероциклични групи,получаване и приложението им
SE8404065D0 (sv) Novel biologically active compounds
ATE119890T1 (de) Aminoketonderivate und ihre verwendung.
NO872382D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
DE69004815D1 (de) 1,8-Benzonaphthyridinderivate, ihre Herstellung und diese enthaltende Zusammensetzungen.
IL66835A0 (en) Triazoloquinazolone derivatives and their salts,their preparation,their use as medicaments and the compositions containing them
ATE21248T1 (de) Derivate von 1h,3h-pyrrolo(1,2-c)thiazol, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DK415789D0 (da) Tetracykliske antidepressive midler
ATE69220T1 (de) Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen.
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
IL82244A (en) Five-membered heterocyclic derivatives of n'-substituted-n,n'-diacylhydrazines and their use as insecticides
FR2449677A1 (fr) Nouveaux derives de benzoyl-2 glycylanilides substitues, leur preparation et leur application en tant que medicaments anxiolytiques
ATE38675T1 (de) Phosphatesterderivate und ihre verwendung als anti-krebsmittel.
ATE61355T1 (de) 2,5-dimethylpyrrolderivative, ihre herstellung und ihre verwendung.
DE69005319D1 (de) 1,8-Benzonaphthyridinderivate und ihre Herstellung.
IL83216A (en) 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
FR2632522B1 (fr) Nouveaux derives de la phenothiazine, leur preparation et les compositions qui les contiennent
ES2101531T3 (es) Derivados de benzo(f)quinoxalinadiona, su preparacion y su utilizacion en medicamentos.
ES2058182T3 (es) Analogos de mitomicina. un procedimiento para su preparacion y composiciones farmaceuticas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MITSUI CHEMICALS, INC., TOKIO/TOKYO, JP

8339 Ceased/non-payment of the annual fee